Exor 20 mg Capsule is a medicine that reduces the amount of acid your stomach produces. It is used for conditions linked to excess stomach acid, such as heartburn and reflux.
There are 161 brands of Esomeprazole listed in Bangladesh. 18 of them have a lower unit price than Exor. The lowest listed price is Emo 20 mg Tablet at ৳ 1 per unit.
What is Exor 20 mg Capsule?
Exor 20 mg Capsule contains esomeprazole, a proton pump inhibitor. It works by blocking the tiny pumps in the stomach lining that release acid, so less acid flows into the stomach. This helps relieve symptoms like heartburn and allows irritated tissue in the food pipe to heal. Doctors prescribe it for reflux disease, erosive esophagitis, and, with other medicines, to clear H. pylori infection in people with duodenal ulcers. Each capsule is taken by mouth. Your doctor will decide the right dose and how long you need to take it.
Uses of Exor
Exor 20 mg Capsule is used to ease chronic heartburn and other symptoms of gastroesophageal reflux disease (GERD). It helps heal erosive esophagitis, a condition where acid damages the food pipe, and can be continued to keep it healed. It is also used together with two antibiotics to treat Helicobacter pylori infection in people with duodenal ulcer disease. Your doctor will confirm whether this medicine is suitable for your condition.
How to use Exor
Take Exor 20 mg Capsule exactly as your doctor tells you. Swallow the capsule whole with water, at least one hour before a meal. If swallowing is difficult, you may open the capsule and mix the small pellets with a tablespoon of soft, cold applesauce, then swallow it straight away without chewing. Do not crush or chew the pellets. The dose and length of treatment are set by your doctor, so follow their instructions and ask a pharmacist if anything is unclear.
Side effects of Exor
Common side effects of esomeprazole include headache, diarrhoea, nausea, wind, stomach pain, constipation, and dry mouth. These are usually mild. Tell your doctor if they bother you or do not go away. Contact your doctor right away if you notice severe or unusual symptoms, such as a skin rash, swelling, difficulty breathing, or persistent vomiting. Serious side effects are uncommon, but your doctor can advise you on what to watch for during treatment.
Safety and precautions
Do not take Exor 20 mg Capsule if you are allergic to esomeprazole or any ingredient in the capsule. Before starting, tell your doctor if you have liver problems or are taking other medicines, as some drugs can interact with esomeprazole. There are no adequate studies of this medicine in pregnant women; animal studies did not show harm to the unborn baby. It is not known if esomeprazole passes into breast milk, so breastfeeding may need to be stopped if the medicine is essential. Always ask your doctor first if you are pregnant, planning pregnancy, or breastfeeding.
Frequently asked questions
What is Exor 20 mg Capsule used for and what kind of medicine is it?
Exor 20 mg Capsule is a proton pump inhibitor. It reduces stomach acid and is used for heartburn and other GERD symptoms, to heal and maintain healing of erosive esophagitis, and with antibiotics to treat H. pylori infection in duodenal ulcer disease. Your doctor will decide if it is right for you.
What side effects should I watch for and when should I call my doctor?
Common side effects include headache, diarrhoea, nausea, wind, stomach pain, constipation, and dry mouth. Call your doctor if these are severe or persistent, or if you have a rash, swelling, or trouble breathing. Your doctor can give you advice on what to watch for.
What does the generic name esomeprazole mean?
Esomeprazole is the generic name of the active ingredient in Exor 20 mg Capsule. It belongs to a group of medicines called proton pump inhibitors. The generic name helps identify the medicine regardless of the brand.
To relieve from chronic heartburn symptoms and other symptoms associated with GERD
For the healing of erosive esophagitis
For maintenance of healing of erosive esophagitis
In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease.
... Read more
Esomeprazole is indicated:
To relieve from chronic heartburn symptoms and other symptoms associated with GERD
For the healing of erosive esophagitis
For maintenance of healing of erosive esophagitis
In combination with amoxicillin and clarithromycin for eradication of Helicobacter pylori infection in patients with duodenal ulcer disease.
Zollinger-Ellison Syndrome
Acid related Dyspepsia
Duodenal & Gastric ulcer
Pharmacology
Esomeprazole is a proton pump inhibitor that suppresses gastric acid secretion by specific inhibition of the H+/K+-ATPase in the gastric parietal cell. Esomeprazole (S-isomer of omeprazole) is the first single optical isomer of proton pump inhibitor, provides better acid control than racemic proton pump inhibitors.
Absorption: Esomeprazole capsules contain an enteric-coated pellet formulation of esomeprazole magnesium. After oral administration peak plasma levels (Cmax) occur at approximately 1.5 hours (Tmax). The Cmax increases proportionally when the dose is increased, and there is a three-fold increase in the area under the plasma concentration-time curve (AUC) from 20 to 40 mg. At repeated once daily dosing, the systemic bioavailability is approximately 90% compared to 64% after a single dose. The AUC after administration of a single dose of esomeprazole is decreased by 33-53% after food intake compared to fasting conditions. Esomeprazole should be taken at least one hour before meals.
Distribution: Esomeprazole is 97% bound to plasma proteins. Plasma protein binding is constant over the concentration range of 2 20 mmol/L. The apparent volume of distribution at steady state in healthy volunteers is approximately 16 L.
Metabolism: Esomeprazole is extensively metabolized in the liver by the cytochrome P450 (CYP) enzyme system. The metabolites of esomeprazole lack anti-secretory activity. The major part of esomeprazole’s metabolism is dependent upon the CYP2C19 isoenzyme, which forms the hydroxy and desmethyl metabolites. The remaining amount is dependent on CYP3A4 which forms the sulphone metabolite.
Excretion: The plasma elimination half-life of esomeprazole is approximately 1–1.5 hours. Less than 1% of parent drug is excreted in the urine. Approximately 80% of an oral dose of esomeprazole is excreted as inactive metabolites in the urine, and the remainder is found as inactive metabolites in the faeces.
Combination Therapy with Antimicrobials: Esomeprazole magnesium 40 mg once daily is given in combination with clarithromycin 500 mg twice daily and amoxicillin 1000 mg twice daily for 7 days. The mean steady state AUC and Cmax of Esomeprazole increased by 70% and 18%, respectively, during triple combination therapy compared to treatment with Esomeprazole alone. The pharmacokinetic parameters for clarithromycin and amoxicillin are similar during triple combination therapy and administration of each drug alone. However, the mean AUC and Cmax for 14-hydroxyclarithromycin are increased by 19% and 22%, respectively, during triple combination therapy compared to treatment with clarithromycin alone. This increase in exposure to 14-hydroxyclarithromycin is not considered to be clinically significant.
Dosage & Administration
Healing of Erosive Esophagitis: 20 mg or 40 mg Once Daily for 4-8 Weeks. The majority of patients are healed within 4 to 8 weeks. For patients who don't heal after 4-8 weeks, an additional 4-8 weeks of treatment may be considered. Maintenance of Healing of Erosive
Esophagitis: 20 mg Once Daily (Clinical studies did not extend 6 months).
Symptomatic GERD: 20 mg Once Daily for 4 Weeks. If symptoms do not resolve completely after 4 weeks, an additional 4 weeks of treatment may be considered.
Helicobacter Pylori eradication: Triple Therapy to reduce the risk of Duodenal Ulcer recurrence-Esomeprazole 40 mg Once Daily for 10 days, Amoxicillin 1000 mg Twice Daily for 10 days, Clarithromycin 500 mg Twice Daily for 10 days.
Zollinger-Ellison Syndrome: The dose is 20-80 mg once daily. The dosage should be adjusted individually and treatment continued as long as clinically indicated.
Acid-related Dyspepsia: 20-40 mg once daily for 2-4 weeks according to the response.
Duodenal ulcer: 20 mg once daily for 2-4 weeks. Gastric ulcer: 20-40 mg once daily for 4-8 weeks.
Injection: The recommended adult dose is 40 mg Esomeprazole given once daily by intravenous injection (not less than 3 minutes) or intravenous infusion (10 to 30 minutes). Esomeprazole IV injection should not be administered concomitantly with any other medications through the same intravenous site. Treatment with Esomeprazole IV injection should be discontinued as soon as the patient is able to resume treatment with Esomeprazole delayed-release capsules. Safety and effectiveness in paediatric patients have not been established.
Interaction
Esomeprazole is extensively metabolized in the liver by CYP2C19 and CYP3A4. In vitro and in vivo studies have shown that Esomeprazole is not likely to inhibit CYPs 1A2, 2A6, 2C9, 2D6, 2E1 and 3A4. No clinically relevant interactions with drugs metabolized by these CYP enzymes would be expected. Drug interaction studies have shown that Esomeprazole does not have any clinically significant interactions with phenytoin, warfarin, quinidine, clarithromycin or amoxicillin.
Esomeprazole may potentially interfere with CYP2C19, the major Esomeprazole metabolizing enzyme. Co-administration of Esomeprazole 30 mg and diazepam, a CYP2C19 substrate has resulted in a 45% decrease in clearance of diazepam. Increased plasma levels of diazepam have been observed 12 hours after dosing and onwards. Esomeprazole inhibits gastric acid secretion. Therefore, Esomeprazole may interfere with the absorption of drugs where gastric pH is an important determinant of bioavailability (e.g., ketoconazole, iron salts and digoxin).
Co-administration of oral contraceptives, diazepam, phenytoin, or quinidine do not seem to change the pharmacokinetic profile of Esomeprazole.
Combination Therapy with Clarithromycin: Co-administration of esomeprazole, clarithromycin, and amoxicillin has resulted in increases in the plasma levels of esomeprazole and 14-hydroxyclarithromycin.
Contraindications
Esomeprazole is contraindicated in-patient with known hypersensitivity to any of the formulation.
Side Effects
The most frequently occurring adverse events reported with Esomeprazole include headache, diarrhoea, nausea, flatulence, abdominal pain, constipation and dry mouth. There are no difference in types of related adverse events seen during maintenance treatment upto 12 months compared to short term treatment.
Pregnancy & Lactation
There are no adequate and well-controlled studies in pregnant women. Animal studies have revealed no teratogenic effects. The excretion of esomeprazole in milk has not been studied. Breast-feeding should be therefore be discontinued if the use of esomeprazole is considered essential.
Precautions & Warnings
General: Symptomatic response to therapy with esomeprazole does not preclude the presence of gastric malignancy.
Information for patients: Esomeprazole capsules should be taken at least one hour before meals. For patients who have difficulty swallowing capsules, one tablespoon of applesauce can be added to an empty bowl and the Esomeprazole capsules can be opened, and the pellets inside the capsule carefully emptied onto the applesauce. The pellets should be mixed with the applesauce and then swallowed immediately. The applesauce used should not be hot and should be soft enough to be swallowed without chewing. The pellets should not be chewed or crushed. The pellet/applesauce mixture should not be stored for future use. Antacids may be used while taking esomeprazole.
Overdose Effects
A single oral dose of Esomeprazole at 510 mg/kg (about 103 times the human dose on a body surface area basis), has been lethal to rats. The major signs of acute toxicity are reduced motor activity, changes in respiratory frequency, tremor, ataxia, and intermittent clonic convulsions. There have been no reports of overdose with Esomeprazole. No specific antidote for Esomeprazole is known. Since Esomeprazole is extensively protein bound, it is not expected to be removed by dialysis. In the event of overdosage, treatment should be symptomatic and supportive. As with the management of any overdose, the possibility of multiple drug ingestion should be considered.
Storage Conditions
Store at a temperature not exceeding 30°C in a dry place. Protect from light and moisture. Keep out of reach of children.
Alternative brands of Esomeprazole
Other brands with the same generic name, cheapest first.